The most fun part about the conference, to me, was to see all these new cool use cases popping up, where our customers are innovating and starting to ingest device-generated data and do analysis on it.
Bristol chief executive Lamberto Andreotti, 60, who took over last May, has built on the strategy put in place by drug-and-medical-device industry veteran James Cornelius, who ran the company for four years starting in 2006.